Pura Vida Investments, LLC Dexcom Inc Call Options Transaction History

Pura Vida Investments, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 Feb 12, 2021	BUY	$28.07 - $38.18 $416,839 - $566,973	14,850 Added 9900.0%	15,000 $1.79 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $1.4 Million - $1.9 Million	-49,850 Reduced 99.7%	150 $74,000
Q3 2018 Feb 11, 2021	BUY	$23.35 - $36.72 $1.16 Million - $1.82 Million	49,500 Added 9900.0%	50,000 $7.15 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $11,675 - $18,360	500 New	500 $798,000
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $611,600 - $845,900	-55,000 Closed	0 $0
Q3 2017 Nov 17, 2017	SELL	$11.36 - $18.98 $624,800 - $1.04 Million	-55,000 Reduced 50.0%	55,000 $165 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1.25 Million - $2.09 Million	110,000	110,000 $194 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.